Bleomycin Electrosclerotherapy and Skin Hyperpigmentation in Slow-flow Vascular Malformations: A Retrospective Monocentric Analysis
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.10.2026 · 198 (10) · 1302-1309
DOI: 10.1055/a-2783-4420 ↗Kurz gefasst
Fachartikel in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.10.2026. Verfasst von Julius Henry Loeser und 8 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Halle, University Hospital and Polyclinic for Radiology, Sachsen-Anhalt, Germany, Halle (Saale). Hauptthemen laut MEDLINE: Bleomycin, Vascular Malformations, Sclerotherapy, Hyperpigmentation. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Sclerotherapy remains the standard for interventional treatment of slow-flow vascular malformations. However, bleomycin electrosclerotherapy (BEST) has shown promising results in the management of recurrent lesions. One notable adverse effect of BEST is the postinterventional development of skin hyperpigmentation. The aim of this study is the analysis of accidental skin hyperpigmentation after BEST of slow-flow vascular malformations. This retrospective study at our interdisciplinary vascular anomalies center investigated the occurrence of skin hyperpigmentation after bleomycin electrosclerotherapy of slow-flow vascular malformations over a period of 21 months documented clinically and in photographic findings, as well as related interventional treatment parameters with subsequent exploratory threshold analyses at 0.10 and 0.15 mg/kg. Subsequently, a comparison was made with recent publications reporting hyperpigmentation after bleomycin administration. During the observation period, 72 patients were included with a total of 80 BEST procedures. Bleomycin-related skin hyperpigmentation was documented in 4 of 7 lymphatic malformation (LMs), 20 of 44 venous malformation (VM)and in 16 of 29 combined venolymphatic vascular malformations associated with other anomalies. On average, 27.1 application series of reversible electroporation per intervention were performed (range 1–85). An average of 8.37 mg bleomycin was administered to LMs, 5.31 mg to VMs and 8.03 mg to the combined group in each session. Hyperpigmentation was more frequent with the hexagonal electrode: 33/56 (58,9 %); Needle-Foil Electrode (NFD) 6/19, Variable Geometry Device (VGD) 1/5. Rates were similar across entities (hexagonal: LM 3/5, VM 17/31, combined 13/20). Overall, bleomycin was administered intralesional 46 times with an average dose of 0.09 mg/kg bw (range 0.008–0.23) and intravenously 34 times, 0.22 mg/kg bw (range 0.13–0.5). Hyperpigmentation was more frequent after intravenous administration (61.8 %) than intralesional (41.3 %), likely reflecting higher dosing. A threshold dose of ≥0.10 mg/kg bleomycin was associated with a higher risk ratio for hyperpigmentation (RR 2.30, 95% CI 1.27–4.15). The frequency of skin hyperpigmentation following BEST seems to be analog to bleomycin-induced flagellate dermatitis and appears more frequently when using the hexagonal electrode and a higher bleomycin dosage per kg bodyweight (bw).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University Hospital Halle, University Hospital and Polyclinic for Radiology, Sachsen-Anhalt, Germany, Halle (Saale).
- University Hospital Halle, University Clinic and Polyclinic for Dermatology, Sachsen-Anhalt, Germany, Halle (Saale).
- University Hospital Halle, University Clinic for Anesthesiology and Operative Intensive Care Medicine, Sachsen-Anhalt, Germany, Halle (Saale).
ORCID-Profile: Julius Henry Loeser
Zitieren
APA
Loeser, J. H., Schramm, D., Cucuruz, B. R., Gussew, A., Stadie, V., Flöther, L., Kaluheresku, O., Schob, S., & Wohlgemuth, W. A. (2026). Bleomycin Electrosclerotherapy and Skin Hyperpigmentation in Slow-flow Vascular Malformations: A Retrospective Monocentric Analysis. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 198(10), 1302-1309. https://doi.org/10.1055/a-2783-4420
Vancouver
Loeser JH, Schramm D, Cucuruz BR, Gussew A, Stadie V, Flöther L, et al. Bleomycin Electrosclerotherapy and Skin Hyperpigmentation in Slow-flow Vascular Malformations: A Retrospective Monocentric Analysis. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2026;198(10):1302-1309. doi:10.1055/a-2783-4420
BibTeX
@article{Loeser2026,
author = {Loeser, Julius Henry and Schramm, Dominik and Cucuruz, Beatrix Rita and Gussew, Alexander and Stadie, Volker and Flöther, Lilit and Kaluheresku, Olena and Schob, Stefan and Wohlgemuth, Walter A},
title = {Bleomycin Electrosclerotherapy and Skin Hyperpigmentation in Slow-flow Vascular Malformations: A Retrospective Monocentric Analysis},
journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
year = {2026},
volume = {198},
number = {10},
pages = {1302--1309},
doi = {10.1055/a-2783-4420}
}
EUVIMED